Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTB4R2 | Q9NPC1 | 13/20 | 0.50 |
| ▸ | AGTR1 | P30556 | 5/20 | 0.46 |
| ▸ | OXTR | P30559 | 1/20 | 0.41 |
| ▸ | AVPR1A | P37288 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.40 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.40 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1711 | 0.86 | LTB4R2 (0.49) | LTB4R2AGTR1OXTRAVPR1AFFAR1 | |
| SCHEMBL2628 | 0.85 | LTB4R2 (0.54) | LTB4R2AGTR1MMEFFAR1AKR1B1 | |
| SCHEMBL2629 | 0.85 | LTB4R2 (0.54) | LTB4R2AGTR1MMEFFAR1AKR1B1 | |
| SCHEMBL1900 | 0.84 | LTB4R2 (0.53) | LTB4R2AGTR1OXTRAVPR1AFFAR1 | |
| SCHEMBL2225 | 0.83 | LTB4R2 (0.54) | LTB4R2AGTR1OXTRAVPR1A | |
| SCHEMBL2032 | 0.83 | AGTR1 (0.66) | LTB4R2AGTR1MMEFFAR1AKR1B1 | |
| SCHEMBL1808771 | 0.83 | AGTR1 (0.66) | LTB4R2AGTR1MMEFFAR1AKR1B1 | |
| SCHEMBL2033 | 0.83 | AGTR1 (0.66) | LTB4R2AGTR1MMEFFAR1AKR1B1 | |
| SCHEMBL29561367 | 0.83 | AGTR1 (0.66) | LTB4R2AGTR1MMEFFAR1AKR1B1 | |
| SCHEMBL1986 | 0.82 | LTB4R2 (0.53) | LTB4R2AGTR1OXTRAVPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5965592-A | HYPOTENSIVE AGENTS | NOVARTIS CORPORATION (US) | 1999-10-12 | — | — | US | disclosed |
| EP-0443983-B1 | Acyl compounds | CIBA GEIGY AG (CH) | 1996-02-28 | — | — | EP | disclosed |
| US-5399578-A | Hypotensive; valsartan; high blood pressure and cardiac insufficiency | CIBA-GEIGY CORP (US) | 1995-03-21 | — | — | US | disclosed |
| EP-0443983-A1 | Acyl compounds | CIBA-GEIGY AG (CH) | 1991-08-28 | — | — | EP | disclosed |